Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Shouguang Juneng Golden Corn is a prominent Chinese enterprise specializing in the deep processing of corn and the production of bio-fermented products. The company is a major global supplier of corn-derived ingredients, including corn starch, modified starch, and sweeteners such as dextrose monohydrate and maltodextrin. In the life sciences sector, it is particularly recognized for its large-scale production of amino acids, including L-Lysine, L-Threonine, and L-Tryptophan, which are utilized in animal nutrition and pharmaceutical applications. The company operates advanced fermentation and refining facilities, maintaining international quality standards to serve both domestic and export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Shaouguang Juneng Golden Corn.